PRINT THIS PAGE Burrill closes life sciences fund below target at $211m13/01/2004. Source: AltAssets. 
 Burrill & Company has announced a final close on its Burrill Life Sciences Fund with total commitments of $211m. The fund was initially targeting $250m.
‘We’re very excited to have successfully completed our fundraising in a very difficult venture capital fundraising environment,’ said Steven Burrill, CEO of Burrill & Company.
The Burrill Life Sciences Capital Fund will invest in companies in the biotechnology, therapeutics, diagnostics, pharmaceuticals, and devices sectors. The firm will make investments of between $5m and $15m and anticipates a portfolio of between 20 and 40 companies.
Copyright © 2004 AltAssets
|
